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Background
We previously demonstrated that vaccination of lactat-
ing rhesus monkeys with a DNA prime/ vector boost
strategy induces strong SIV-specific cellular immune
responses, but limited Envelope-specific humoral
responses in breast milk. Therefore, we sought to
improve vaccine-elicited Envelope-specific antibody
responses in the milk compartment by using a trans-
mitted/founder (T/F) HIV Envelope immunogen in a
prime-boost strategy modeled after that of the moder-
ately-successful RV144 HIV vaccine trial.
Methods
Eight female, hormone-induced lactating rhesus mon-
keys were intramuscularly primed with either recombi-
nant DNA (n = 4) or MVA pox virus vector (n = 4)
expressing the T/F clade C HIV Envelope 1086C. All
animals were intramuscularly boosted twice with the
1086C gp120 protein and the adjuvant MF59. Milk,
vaginal, rectal and plasma samples were assessed for
HIV Envelope-binding IgG and IgA responses. Anti-
V1V2 antibodies and neutralization responses were also
measured in milk and plasma.
Results
Envelope 1086C-binding IgG responses were detected
in plasma, milk, and vaginal samples of all vaccinated
animals and two of four rectal samples from MVA-
vaccinated animals. Moreover, anti-V1V2 IgG antibodies
were detected in all plasma, but only one milk sample.
Low magnitude Envelope 1086C-specific IgA responses
were detected in milk of two of four DNA-primed and
three of four MVA-primed animals, but in none of the
rectal samples. In contrast, all vaginal samples from
MVA-primed, but none from DNA-primed, animals had
detectable Envelope-specific IgA. Remarkably, strong tier
1 and low to moderate tier 2 neutralization was detected
in plasma and milk of each group. The plasma neutraliza-
tion titers against MW965 (clade C tier 1, p=0.03) and
CAP45 (clade C tier 2, p=0.03) were significantly higher
in MVA-primed than DNA-primed animals.
Conclusion
MVA prime/ T/F Envelope protein boost strategy appears
to induce stronger systemic and mucosal binding and
neutralizing antibody responses than the DNA prime/
protein boost regimen in lactating rhesus monkeys.
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